Burgdorf – On 26th September 2017, groundbreaking took place for Ypsomed’s new production facility in the Industrial Park of Schwerin, Germany. Ypsomed is to invest over EUR 100 million in the new production site. Production will commence during the first half of 2019. Ypsomed plans to create roughly 150 jobs in the region over the next five years.
Groundbreaking heralded the beginning of construction of the new production facility in the Industrial Park Schwerin. Construction will take approximately 18 months. The new plant will start up operations during the first half of 2019. After opening, the Schwerin site will accommodate production, a logistics warehouse, quality control and technical maintenance. On the manufacturing side, production will include injection and infusion systems as well as infusion sets for insulin pumps. The facility will be equipped with state-of-the-art cleanrooms, plastic injection moulding machines, printing equipment and automated assembly and packaging machines. During the initial five years, the new site will create some 150 jobs in the region. Additional jobs will be created as production increases.
As the production sites in Switzerland have been expanded to the limit and production capacities will be exhausted after 2020, Ypsomed has decided to increase capacities in Schwerin, in Germany’s northeast. “The Schwerin location offers us perfect conditions. Being located in the EU, this provides us with a high level of planning and legal safety. Development of the infrastructure is excellent and the vicinity to the port of Hamburg gives us shorter trading routes. Furthermore, the Schwerin greater area offers an ample pool of qualified employees” is how Simon Michel, CEO of the Ypsomed Group, comments the step to Germany.
Groundbreaking was not only attended by Ypsomed’s Management, but also included Minister Harry Glawe, Minister of Economic Affairs of the state Mecklenburg-Western Pomerania, and Schwerin’s Mayor, Dr. Rico Badenschier. Minister Glawe welcomed Ypsomed’s step to Schwerin: “The Ypsomed company is investing into the field of medical engineering, an area which is very important for us. Innovative products will be manufactured and high-quality jobs created in Mecklenburg-Western Pomerania. I am pleased that our location advantages were able to convince the Swiss company. This new establishment is confirmation of the attractive business location Mecklenburg-Western Pomerania. It is also the result of intensive campaigning in Switzerland in an exciting growth market. Welcome to Mecklenburg-Western Pomerania.”
Facts and figures on the new Ypsomed production site Schwerin:
- 100’000 m2 land, option for a further 2 x 50’000 m2
- 20’000 m2 building area
- EUR 50 million planning and construction costs
- EUR 50 million investment in production equipment
- 18 months construction time, completion of building and start of production during the first half of 2019
- Approximately 150 jobs over the first five years with additional jobs as production increases